The Neuroscientist

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register today!

Click here to register today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, F.-M.
Right arrow Articles by Dani, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, F.-M.
Right arrow Articles by Dani, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Neuroscientist, Vol. 9, No. 1, 23-36 (2003)
DOI: 10.1177/1073858402239588
© 2003 SAGE Publications

Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems

Fu-Ming Zhou

Charles Wilson

John A. Dani

The striatum and its dense dopaminergic innervation originating in the midbrain, primarily from the substantia nigra pars compacta and the ventral tegmental area, compose the mesostriatal dopamine (DA) systems. The nigrostriatal system is involved mainly in motor coordination and in disorders such as Tourette’s syndrome, Huntington’s disease, and Parkinson’s disease. The dopaminergic projections from the ventral tegmental area to the striatum participate more in the processes that shape behaviors leading to reward, and addictive drugs act upon this mesolimbic system. The midbrain DA areas receive cholinergic innervation from the pedunculopontine tegmentum and the laterodorsal pontine tegmentum, whereas the striatum receives dense cholinergic innervation from local interneurons. The various neurons of the mesostriatal systems express multiple types of muscarinic and nicotinic acetylcholine receptors as well as DA receptors. Especially in the striatum, the dense mingling of dopaminergic and cholinergic constituents enables potent interactions. Evidence indicates that cholinergic and dopaminergic systems work together to produce the coordinated functioning of the striatum. Loss of that cooperative activity contributes to the dysfunction underlying Parkinson’s disease.

Key Words: Acetylcholine • Basal ganglia • Dopamine • Mesolimbic • Nigrostriatal • Nucleus accumbens • Parkinson’s disease • Striatum • Substantia nigra • Ventral tegmental area


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
O. V. Poisik, J.-x. Shen, S. Jones, and J. L. Yakel
Functional {alpha}7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata
J. Physiol., March 1, 2008; 586(5): 1365 - 1378.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Cubo, K. M. Shannon, D. Tracy, J. A. Jaglin, B. A. Bernard, J. Wuu, and S. E. Leurgans
Effect of donepezil on motor and cognitive function in Huntington disease.
Neurology, October 10, 2006; 67(7): 1268 - 1271.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. Perez-Rosello, A. Figueroa, H. Salgado, C. Vilchis, F. Tecuapetla, J. N. Guzman, E. Galarraga, and J. Bargas
Cholinergic Control of Firing Pattern and Neurotransmission in Rat Neostriatal Projection Neurons: Role of CaV2.1 and CaV2.2 Ca2+ Channels
J Neurophysiol, May 1, 2005; 93(5): 2507 - 2519.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. M. Warren, M. A. Piggott, E. K. Perry, and D. J. Burn
Cholinergic systems in progressive supranuclear palsy
Brain, February 1, 2005; 128(2): 239 - 249.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Zhang, F.-M. Zhou, and J. A. Dani
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Mol. Pharmacol., September 1, 2004; 66(3): 538 - 544.
[Abstract] [Full Text] [PDF]